SCHEMBL3105240

SCHEMBL3105240

O=C(O)c1ncsc1C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.59
PKM P14618 1/20 0.59
DAO P14920 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
HKDC1 Q2TB90 1/20 0.37
ALDH1A1 P00352 3/20 0.34
MAPT P10636 2/20 0.34
CYP3A4 P08684 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
BLM P54132 1/20 0.34
AGER Q15109 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ASPH Q12797 1/20 0.32
KDM8 Q8N371 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7851286 0.85 KDM4E (0.53) KDM4EPKMDAOL3MBTL1TDP1
SCHEMBL9631804 0.85 KDM4E (0.59) KDM4EPKMDAOL3MBTL1TDP1
SCHEMBL23896640 0.85 KDM4E (0.53) KDM4EPKMDAOL3MBTL1TDP1
SCHEMBL27699410 0.80 KDM4E (0.53) KDM4EPKMDAONPC1RAB9A
SCHEMBL8083454 0.79
SCHEMBL7853664 0.78 KDM4E (0.50) KDM4EPKMDAOL3MBTL1TDP1
SCHEMBL7842661 0.78 KDM4E (0.54) KDM4EPKMDAOL3MBTL1TDP1
SCHEMBL20783705 0.78 KDM4E (0.70) KDM4EPKMDAOL3MBTL1TDP1
SCHEMBL5011865 0.78 KDM4E (0.61) KDM4EPKMDAOL3MBTL1TDP1
SCHEMBL27766706 0.76 KDM4E (0.50) KDM4EPKML3MBTL1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119836101-A Perovskite solar cell based on diamine molten salt surface modification and preparation method thereof 东方电气长三角(杭州)创新研究院有限公司 2025-04-15 CN claimed
CN-117966225-B QFP blister copper electroplating solution, preparation method and electroplating method 昆山一鼎工业科技有限公司 2024-07-16 CN claimed
CN-117966225-A QFP blister copper electroplating solution, preparation method and electroplating method 昆山一鼎工业科技有限公司 2024-05-03 CN claimed
WO-2026100662-A1 LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2026-05-15 WO disclosed
US-20250348000-A1 RESIST UNDERLAYER FILM-FORMING COMPOSITION NISSAN CHEMICAL CORPORATION (JP) 2025-11-13 US disclosed
US-20250155813-A1 PROTECTIVE FILM FORMING COMPOSITION NISSAN CHEMICAL CORPORATION (JP) 2025-05-15 US disclosed
CN-119836101-A Perovskite solar cell based on diamine molten salt surface modification and preparation method thereof 东方电气长三角(杭州)创新研究院有限公司 2025-04-15 CN disclosed
US-20250066290-A1 DHODH INHIBITORS CONTAINING A CARBOXYLIC ACID BIOISOSTERE IMMUNIC AG (DE) 2025-02-27 US disclosed
WO-2025033304-A1 METHOD FOR MANUFACTURING LIQUID CRYSTAL ALIGNMENT FILM, AND METHOD FOR MANUFACTURING LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2025-02-13 WO disclosed
WO-2024223872-A1 PROCESS GIVAUDAN SA (CH) 2024-10-31 WO disclosed
EP-4452929-A1 DHODH INHIBITORS CONTAINING A CARBOXYLIC ACID BIOISOSTERE Immunic AG (DE) 2024-10-30 EP disclosed
WO-2007117453-A2 RADIOSYNTHESIS AS AN ALTERNATIVE ENERGY UTILIZATION PROCESS IN MELANIZED ORGANISMS AND USES THEREOF ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2007-10-18 WO disclosed
US-20070237829-A1 Melanin nanoshells for protection against radiation and electronic pulses ALBERT EINSTEIN COLLEGE OF MEDICINE 2007-10-11 US disclosed
US-20070190344-A1 Verification of translation JNC CORPORATION (JP) 2007-08-16 US disclosed
WO-2006124056-A2 MELANIN NANOSHELLS FOR PROTECTION AGAINST RADIATION AND ELECTRONIC PULSES ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2006-11-23 WO disclosed
US-20060204192-A1 Optical waveguide using polymer composed of silsesquioxane derivative JNC CORPORATION (JP) 2006-09-14 US disclosed
US-20060204680-A1 Varnish for forming liquid crystal alignment layer and liquid crystal display element using the same JNC CORPORATION (JP) 2006-09-14 US disclosed
US-20060039858-A1 Radiolabeled antibodies and peptides for treatment of tumors NATIONAL INSTITUTES OF HEALTH 2006-02-23 US disclosed
US-6949281-B1 Varnish composition and liquid-crystal display element CHISSO CORPORATION (JP) 2005-09-27 US disclosed
US-20050009982-A1 Compound having silsesquioxane skeleton and its polymer CHISSO CORPORATION (JP) 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066290-A1 DHODH INHIBITORS CONTAINING A CARBOXYLIC ACID BIOISOSTERE DHODH, DBH, DOHH KDM4E 2435/4885PKM 2560/4885DAO 11/4885
US-20050009982-A1 Compound having silsesquioxane skeleton and its polymer C1S, H1-4, H1-0 KDM4E 349/4885PKM 1898/4885DAO 2540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.